Medco 2014 Annual Report Download - page 49
Download and view the complete annual report
Please find page 49 of the 2014 Medco annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.47
Express Scripts 2014 Annual Report
The2013ASRAgreementwasaccountedforasaninitialtreasurystocktransactionandaforwardstockpurchase
contract.Werecordedthistransactionasanincreasetotreasurystockof$1,350.1million,andrecordedtheremaining$149.9
millionasadecreasetoadditionalpaid-incapitalintheconsolidatedbalancesheetatDecember31,2013.The$149.9million
recordedinadditionalpaid-incapitalwasreclassifiedtotreasurystockuponcompletionofthe2013ASRProgramonApril16,
2014.Theforwardstockpurchasecontractwasclassifiedasanequityinstrumentandwasdeemedtohaveafairvalueofzero
attheeffectivedateofthe2013ASRAgreement.Theinitialdeliveryofsharesresultedinanimmediatereductionofthe
outstandingsharesusedtocalculatetheweighted-averagecommonsharesoutstandingforbasicanddilutednetincomeper
shareontheeffectivedateofthe2013ASRAgreement.Theremaining0.6millionsharesreceivedforthesettlementtothe
ASRProgramreducedweighted-averagecommonsharesoutstandingfortheyearendedDecember31,2014.
STOCK REPURCHASE PROGRAM
IneachofMarch2014andDecember2014,theBoardofDirectorsofExpressScriptsapprovedanincreaseinthe
authorizednumberofsharesthatmaybepurchasedunderthesharerepurchaseprogram(the“ShareRepurchaseProgram”),
originallyannouncedandexecutedduring2013.Eachauthorizationapprovedanadditional65.0millionshares,foratotal
authorizationof205.0millionshares(includingsharespreviouslypurchased,asadjustedforanysubsequentstocksplit,stock
dividendorsimilartransaction)oftheCompany’scommonstock.
Includingthesharesrepurchasedthroughthe2013ASRProgram,werepurchased62.1millionand60.4million
sharesfor$4,642.9millionand$3,905.3millionduringtheyearsendedDecember31,2014and2013,respectively.Additional
sharerepurchases,ifany,willbemadeinsuchamountsandatsuchtimesastheCompanydeemsappropriatebasedupon
prevailingmarketandbusinessconditionsandotherfactors.AsofDecember31,2014,therewere83.7millionshares
remainingundertheShareRepurchaseProgram.Currentyearrepurchaseswerefundedthroughinternallygeneratedcashand
debt.
UponconsummationoftheMergeronApril2,2012,allESIsharesheldintreasurywerenolongeroutstandingand
werecancelledandretiredandceasedtoexist.SeeNote9-Commonstock.
SENIOR NOTES
FollowingtheconsummationoftheMergeronApril2,2012,severalseriesofseniornotesissuedbyMedcoare
reportedasdebtobligationsofExpressScripts.ThebelowdescriptionreflectstheredemptionactivityoftheCompanyforthe
yearsendedDecember31,2014and2013.SeeNote7-Financingforacompletesummaryofoutstandingseniornotes.
TheJune2014seniornotes(the“June2014SeniorNotes”)consistof:
• $500.0millionaggregateprincipalamountof1.250%seniornotesdue2017
• $1,000.0millionaggregateprincipalamountof2.250%seniornotesdue2019
• $1,000.0millionaggregateprincipalamountof3.500%seniornotesdue2024
AportionofthenetproceedsfromthesaleoftheJune2014SeniorNoteswasusedtoredeemalloftheCompany’s
outstanding3.500%seniornotesdue2016inJuly2014andtopayforaportionoftheCompany’soutstanding2.750%senior
notesdue2014attheirmaturityonNovember15,2014,andtheremainderisforgeneralcorporatepurposes,whichincludes
repurchasesoftheCompany’scommonstockunderitsShareRepurchaseProgrampursuanttoopenmarkettransactions.
InNovember2014,$900.0millionaggregateprincipalamountof2.750%seniornotesdue2014maturedandwere
redeemed.InJuly2014,$1,250.0millionaggregateprincipalamountof3.500%seniornotesdue2016wereredeemed.
InMarch2013,$1,000.0millionaggregateprincipalamountof6.250%seniornotesdue2014wereredeemed.
InMarch2013,$300.0millionaggregateprincipalamountof6.125%seniornotesdue2013maturedandwere
redeemed.
BANK CREDIT FACILITIES
InDecember2014,theCompanyenteredintocreditagreementsprovidingforthreeuncommittedrevolvingcredit
facilities(the“2014creditfacilities”),eachfor$150.0million,whichareavailableforgeneralcorporatepurposes.The2014
creditfacilitiesareavailablefromDecember17,2014untilDecember16,2015,fromJanuary2,2015untilJanuary2,2016
andfromDecember19,2014untilDecember19,2015,respectively.AsofDecember31,2014,noamountsweredrawnunder
the2014creditfacilities.Thematuritydateofeachloandrawnunderthe2014creditfacilitiescanbespecifiedbytheCompany
43